Prosecution Insights
Prosecution Insights
9 pending office actions • 6 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (11%) |
| §101 + other | 1 (11%) |
| §103 only | 3 (33%) |
| Double-patenting + other | 1 (11%) |
| Multi-statute (no §101) | 3 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GANGLE, BRIAN J | 1 | 76.7% | +15.0% |
| CHEUNG, CHUN HOI | 1 | 62.1% | +39.1% |
| BOUCHELLE, LAURA A | 1 | 80.3% | +10.4% |
| GROOMS, TIFFANY NICOLE | 1 | 59.1% | +46.3% |
| WANG, RUIXUE | 1 | 57.4% | +22.1% |
| OUSPENSKI, ILIA I | 1 | 77.5% | +20.4% |
| VU, QUYNH-NHU HOANG | 1 | 68.3% | +27.5% |
| KOO, BENJAMIN K | 1 | 57.3% | +49.3% |
| SIMMONS, VALERIE MICHELLE | 1 | 30.2% | +50.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18858778 | VIAL HOLDER | CHEUNG, CHUN HOI | 58d overdue |
| 17763600 | MEASURING PARAMETERS ASSOCIATED WITH DRUG ADMINISTRATION AND DRUG ADMINISTRATION DEVICES INCORPORATING SAME | VU, QUYNH-NHU HOANG | 33d |
| 19029331 | MDR E. COLI IMMUNOGEN | GANGLE, BRIAN J | — |
| 17763585 | DRUG DELIVERY ADJUSTMENT | BOUCHELLE, LAURA A | — |
| 18045525 | ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF | OUSPENSKI, ILIA I | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17998592 | STABILIZED CORONAVIRUS SPIKE PROTEIN FUSION PROTEINS | WANG, RUIXUE | 170d overdue |
| 18858778 | VIAL HOLDER | CHEUNG, CHUN HOI | 58d overdue |
| 17763600 | MEASURING PARAMETERS ASSOCIATED WITH DRUG ADMINISTRATION AND DRUG ADMINISTRATION DEVICES INCORPORATING SAME | VU, QUYNH-NHU HOANG | 33d |
| 19029331 | MDR E. COLI IMMUNOGEN | GANGLE, BRIAN J | — |
| 17763585 | DRUG DELIVERY ADJUSTMENT | BOUCHELLE, LAURA A | — |
| 18498448 | COMPOSITIONS AND METHODS FOR ENHANCING GENE EXPRESSION | GROOMS, TIFFANY NICOLE | — |
| 18045525 | ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF | OUSPENSKI, ILIA I | — |
| 17763602 | DRUG ADMINISTRATION SYSTEM CONFIGURED TO DETERMINE A DRUG DOSING SCHEME | KOO, BENJAMIN K | — |
| Art Unit | Apps |
|---|---|
| 3783 | 3 |
| 3736 | 1 |
| 1637 | 1 |
| 1672 | 1 |
| 1644 | 1 |
| 1758 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19029331 | MDR E. COLI IMMUNOGEN | GANGLE, BRIAN J | — | §101§112DP | Non-Final OA | — | Pending | Jan 17, 2025 |
| 18858778 | VIAL HOLDER | CHEUNG, CHUN HOI | 3736 | §102§103 | Non-Final OA | 58d overdue | Pending | Oct 22, 2024 |
| 17763585 | DRUG DELIVERY ADJUSTMENT | BOUCHELLE, LAURA A | 3783 | §102§103 | Non-Final OA | — | Pending | Nov 20, 2023 |
| 18498448 | COMPOSITIONS AND METHODS FOR ENHANCING GENE EXPRESSION | GROOMS, TIFFANY NICOLE | 1637 | §103DP | Non-Final OA | — | Pending | Oct 31, 2023 |
| 17998592 | STABILIZED CORONAVIRUS SPIKE PROTEIN FUSION PROTEINS | WANG, RUIXUE | 1672 | §103 | Non-Final OA | 170d overdue | Pending | Nov 11, 2022 |
| 18045525 | ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF | OUSPENSKI, ILIA I | 1644 | §101Other | Non-Final OA | — | Pending | Oct 11, 2022 |
| 17763600 | MEASURING PARAMETERS ASSOCIATED WITH DRUG ADMINISTRATION AND DRUG ADMINISTRATION DEVICES INCORPORATING SAME | VU, QUYNH-NHU HOANG | 3783 | §102§103 | Final Rejection | 33d | Pending | Mar 24, 2022 |
| 17763602 | DRUG ADMINISTRATION SYSTEM CONFIGURED TO DETERMINE A DRUG DOSING SCHEME | KOO, BENJAMIN K | 3783 | §103 | Final Rejection | — | Pending | Mar 24, 2022 |
| 17240648 | METHOD FOR IDENTIFICATION AND QUANTIFICATION OF POLYSACCHARIDES IN COMPLEX GLYCOCONJUGATE COMPOSITIONS | SIMMONS, VALERIE MICHELLE | 1758 | §103 | Final Rejection | — | Pending | Apr 26, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial